Pathologies of the vasculature and microvasculature are often complex in nature, leading to loss of physiological homeostatic regulation of patency and adequate perfusion to match tissue metabolic demands. Contributing pathological factors include endothelial dysfunction, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, loss of angiogenic potential and vascular density, and greater senescence and apoptosis. In many clinical settings, current pharmacologic strategies lack holistic mechanisms whilst addressing symptoms of pathology rather than their root cause. To address this, efforts have been heavily focused on cellular therapies that can tackle the multifaceted etiology of vascular and microvascular dysfunction. In this review, we discuss 1) the state of the field in terms of common therapeutic cell population isolation techniques, their unique characteristics and their advantages and disadvantages, 2) common molecular mechanisms of cell therapies to restore vascularization and/or vascular function, 3) arguments for and against allogenic vs. autologous applications of cell therapies, 4) emerging strategies to optimize and enhance cell therapies through priming and preconditioning, and finally, 5) emerging dosing and administrative strategies to bolster therapeutic effect. Significant clinical and animal studies of emerging cellular therapies to restore vascular function or pathologic tissue health by way of improved vascularization are highlighted throughout these sections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.